UniProt ID | SCNNG_HUMAN | |
---|---|---|
UniProt AC | P51170 | |
Protein Name | Amiloride-sensitive sodium channel subunit gamma | |
Gene Name | SCNN1G | |
Organism | Homo sapiens (Human). | |
Sequence Length | 649 | |
Subcellular Localization |
Apical cell membrane Multi-pass membrane protein . Apical membrane of epithelial cells. |
|
Protein Description | Sodium permeable non-voltage-sensitive ion channel inhibited by the diuretic amiloride. Mediates the electrodiffusion of the luminal sodium (and water, which follows osmotically) through the apical membrane of epithelial cells. Plays an essential role in electrolyte and blood pressure homeostasis, but also in airway surface liquid homeostasis, which is important for proper clearance of mucus. Controls the reabsorption of sodium in kidney, colon, lung and sweat glands. Also plays a role in taste perception.. | |
Protein Sequence | MAPGEKIKAKIKKNLPVTGPQAPTIKELMRWYCLNTNTHGCRRIVVSRGRLRRLLWIGFTLTAVALILWQCALLVFSFYTVSVSIKVHFRKLDFPAVTICNINPYKYSTVRHLLADLEQETREALKSLYGFPESRKRREAESWNSVSEGKQPRFSHRIPLLIFDQDEKGKARDFFTGRKRKVGGSIIHKASNVMHIESKQVVGFQLCSNDTSDCATYTFSSGINAIQEWYKLHYMNIMAQVPLEKKINMSYSAEELLVTCFFDGVSCDARNFTLFHHPMHGNCYTFNNRENETILSTSMGGSEYGLQVILYINEEEYNPFLVSSTGAKVIIHRQDEYPFVEDVGTEIETAMVTSIGMHLTESFKLSEPYSQCTEDGSDVPIRNIYNAAYSLQICLHSCFQTKMVEKCGCAQYSQPLPPAANYCNYQQHPNWMYCYYQLHRAFVQEELGCQSVCKEACSFKEWTLTTSLAQWPSVVSEKWLLPVLTWDQGRQVNKKLNKTDLAKLLIFYKDLNQRSIMESPANSIEMLLSNFGGQLGLWMSCSVVCVIEIIEVFFIDFFSIIARRQWQKAKEWWAWKQAPPCPEAPRSPQGQDNPALDIDDDLPTFNSALHLPPALGTQVPGTPPPKYNTLRLERAFSNQLTDTQMLDEL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Ubiquitination | --MAPGEKIKAKIKK --CCCHHHHHHHHHH | 56.26 | - | |
8 | Ubiquitination | MAPGEKIKAKIKKNL CCCHHHHHHHHHHCC | 55.48 | 9351815 | |
10 | Ubiquitination | PGEKIKAKIKKNLPV CHHHHHHHHHHCCCC | 50.48 | 9351815 | |
12 | Ubiquitination | EKIKAKIKKNLPVTG HHHHHHHHHCCCCCC | 34.60 | 9351815 | |
13 | Ubiquitination | KIKAKIKKNLPVTGP HHHHHHHHCCCCCCC | 68.16 | 9351815 | |
26 | Ubiquitination | GPQAPTIKELMRWYC CCCCCHHHHHHHHHH | 47.47 | 9351815 | |
47 | Phosphorylation | GCRRIVVSRGRLRRL CCEEEEEECHHHHHH | 20.37 | 24719451 | |
98 | Phosphorylation | KLDFPAVTICNINPY CCCCCEEEEECCCCC | 23.17 | - | |
108 | Phosphorylation | NINPYKYSTVRHLLA CCCCCCHHHHHHHHH | 19.10 | - | |
109 | Phosphorylation | INPYKYSTVRHLLAD CCCCCHHHHHHHHHH | 20.61 | - | |
142 | Phosphorylation | RKRREAESWNSVSEG HHHHHHHHHCCCCCC | 38.31 | 29978859 | |
145 | Phosphorylation | REAESWNSVSEGKQP HHHHHHCCCCCCCCC | 22.29 | 28509920 | |
147 | Phosphorylation | AESWNSVSEGKQPRF HHHHCCCCCCCCCCC | 40.21 | 28509920 | |
176 | Phosphorylation | GKARDFFTGRKRKVG CCCCCCCCCCCCEEC | 35.75 | 24719451 | |
185 | Phosphorylation | RKRKVGGSIIHKASN CCCEECCCEEEECCC | 16.67 | 22210691 | |
209 | N-linked_Glycosylation | VGFQLCSNDTSDCAT EEEEEECCCCCCCEE | 56.43 | UniProtKB CARBOHYD | |
495 | Acetylation | QGRQVNKKLNKTDLA HHHHHHHHCCCCHHH | 52.68 | 12649891 | |
497 | N-linked_Glycosylation | RQVNKKLNKTDLAKL HHHHHHCCCCHHHHH | 54.80 | UniProtKB CARBOHYD | |
498 | Acetylation | QVNKKLNKTDLAKLL HHHHHCCCCHHHHHH | 54.58 | 12649903 | |
503 | Acetylation | LNKTDLAKLLIFYKD CCCCHHHHHHHHHHC | 51.64 | 12649915 | |
622 | Phosphorylation | LGTQVPGTPPPKYNT CCCCCCCCCCCCCCC | 26.93 | 11805112 | |
629 | Phosphorylation | TPPPKYNTLRLERAF CCCCCCCCHHHHHHH | 15.34 | - | |
637 | Phosphorylation | LRLERAFSNQLTDTQ HHHHHHHHCCCCCCH | 23.76 | 28857561 | |
641 | Phosphorylation | RAFSNQLTDTQMLDE HHHHCCCCCCHHHHC | 27.51 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SCNNG_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SCNNG_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NEDD4_HUMAN | NEDD4 | physical | 10642508 | |
NEDD4_HUMAN | NEDD4 | physical | 11244092 | |
NED4L_HUMAN | NEDD4L | physical | 11244092 | |
EPN1_HUMAN | EPN1 | physical | 16574660 | |
NED4L_HUMAN | NEDD4L | physical | 16416336 | |
UBP2_HUMAN | USP2 | physical | 18701608 | |
SERP1_HUMAN | SERP1 | physical | 22526458 |
Kegg Disease | |
---|---|
H00242 | Liddle syndrome |
H00243 | Hyperkalemic distal renal tubular acidosis (RTA type 4), including: Pseudohypoaldosteronism type I |
H00892 | Bronchiectasis with or without elevated sweat chloride |
OMIM Disease | |
177200 | Liddle syndrome (LIDDS) |
613071 | Bronchiectasis with or without elevated sweat chloride 3 (BESC3) |
Kegg Drug | |
D00386 | Triamterene (JP16/USP/INN); Dyrenium (TN) |
D00649 | Amiloride hydrochloride (USP); Midamor (TN) |
D07447 | Amiloride (INN); Amiclaran (TN) |
DrugBank | |
DB00594 | Amiloride |
DB00384 | Triamterene |
loading...